Home
Alkem Laboratories Ltd Quarterly Result
Alkem Laboratories Ltd
NSE: ALKEM
Net Profit - Last Quarter
Alkem Laboratories Ltd Quarterly Results Key Highlights
- The revenue of Alkem Laboratories Ltd for the Sep '25 is ₹ 4104 crore as compare to the Jun '25 revenue of ₹ 3520 crore.
- This represent the growth of 16.59%a1# The ebitda of Alkem Laboratories Ltd for the Sep '25 is ₹ 1024 crore as compare to the Jun '25 ebitda of ₹ 888.47 crore.
- This represent the growth of 15.31%a1# The net profit of Alkem Laboratories Ltd for the Sep '25 is ₹ 779.6 crore as compare to the Jun '25 net profit of ₹ 668.32 crore.
- This represent the growth of 16.65%a1#.
Alkem Laboratories Ltd Quarterly Results Analysis
Market Price of Alkem Laboratories Ltd
1M
1Y
3Y
5Y
Last Ten Days Market Price
| Date | |
|---|---|
| 19 Nov 2025 | 5733.15 |
| 18 Nov 2025 | 5711.4 |
| 17 Nov 2025 | 5723 |
| 14 Nov 2025 | 5724.6 |
| 13 Nov 2025 | 5722.2 |
| 12 Nov 2025 | 5765.05 |
| 11 Nov 2025 | 5701.15 |
| 10 Nov 2025 | 5679.2 |
| 07 Nov 2025 | 5674.3 |
| 06 Nov 2025 | 5643.65 |
Historical Revenue of Alkem Laboratories Ltd
Revenue term means the amount of money a company earns from its primary business activities such as the sales of its products & services. Types of Revenue: 1. Operating revenue: It refers to the income generated from the core business activities, which are sales of goods or services rendered. 2. Non-Operating revenue: It is the income generated from secondary sources unrelated to the primary business. Examples include rents, dividends, interest, and royalty fees. Formula for Revenue: The formula for calculating revenue is based on two goods & services: For goods: Revenue = Avg unit price x Number of Units sold For services: Revenue = Avg unit price x Number of Customers served.
Historical Revenue of Alkem Laboratories Ltd
Historical EBITDA of Alkem Laboratories Ltd
PBIDT stands for Profit Before Interest, Depreciation, and Taxes. It is a financial metric that measures a company's profitability before accounting for interest expenses, depreciation of assets, and taxes. Formula to calculate PBIDT: PBIDT = Net Income + Interest + Depreciation + Taxes or PBIDT = Operating Income + Depreciation + Taxes PBIDT vs EBITDA vs EBIT vs EBT: Here is a brief explanation of the differences: - PBIDT (Profit Before Interest, Depreciation, and Taxes) includes taxes in its calculation, unlike EBITDA. - EBITDA (Earnings Before Interest, Taxes, Depreciation, and Amortization) excludes taxes and interest, focusing on operational performance. - EBIT (Earnings Before Interest and Taxes) excludes interest and taxes, providing a measure of core operational profitability. - EBT (Earnings Before Taxes) includes all operating income but does not account for interest expenses. Conclusion: PBIDT, similar to EBITDA, is a measure of operational profitability but includes taxes in its calculation.
Historical EBITDA of Alkem Laboratories Ltd
Historical Net Profit of Alkem Laboratories Ltd
Net profit is the amount of money a company retains after accounting for all expenses, depreciation, interest, taxes, and other deductions. Net Profit formula is expressed as: Net Profit = Total Revenue - Total Expense Net Profit Margin Ratio: Net Profit Margin Ratio = Net Profit / Total Revenue
Historical Net Profit of Alkem Laboratories Ltd
Alkem Laboratories Ltd News Hub
Alkem Labs PAT soars 90% YoY to Rs 545 crore in Q1
Revenue from operations stood at Rs 3,031.82 crore in June 2024 quarter, registering a growth of 2.1
Read more
09 Aug 24
Alkem Laboratories consolidated net profit rises 90.13% in the June 2024 quarter
Net profit of Alkem Laboratories rose 90.13% to Rs 545.16 crore in the quarter ended June 2024 as ag
Read more
09 Aug 24
Alkem Laboratories Ltd soars 3.33%, rises for fifth straight session
Alkem Laboratories Ltd rose for a fifth straight session today. The stock is quoting at Rs 5695.7, u
Read more
08 Aug 24
Alkem Laboratories Ltd rises for third consecutive session
Alkem Laboratories Ltd gained for a third straight session today. The stock is quoting at Rs 5407.35
Read more
06 Aug 24
Document
Concalls
